Are you Dr. Bachtell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 35 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9205 Sw Barnes Rd
5th Floor South
Portland, OR 97225Phone+1 503-216-2906Fax+1 503-216-7106- Is this information wrong?
Summary
- Dr. Nathan Bachtell, MD is an internist in Portland, Oregon. He is currently licensed to practice medicine in Massachusetts.
Education & Training
- Oregon Health & Science UniversityResidency, Internal Medicine, 2000 - 2003
- University of California San Francisco School of MedicineClass of 2000
Certifications & Licensure
- MA State Medical License 2008 - 2012
Publications & Presentations
PubMed
- 4 citationsLocalized inhibition of platelets and platelet derived growth factor by a matrix targeted glycan mimetic significantly attenuates liver fibrosis.Harsha Kabra, Tanaya Walimbe, Kate Stuart, Camille Indey, Swati Jalgaonkar, Elvis Ikwa, Taylor Skurnac, Julia Chen, Andrew J. Woolley, Nicholas M. Snead, Nathan Bachte...> ;Biomaterials. 2021 Feb 1
- 23 citationsNovel Hyaluronic Acid Dermal Filler: Dermal Gel Extra Physical Properties and Clinical OutcomesGary D. Monheit, Leslie Baumann, Michael H. Gold, David J. Goldberg, Mitchel P. Goldman, Rhoda S. Narins, Nathan Bachtell, Emily Garcia, J. Jeffrey Kablik, Julia B. Ge...> ;Dermatologic Surgery. 2010 Nov 1
- 17 citationsDevelopment and validation of a 6-point grading scale in patients undergoing correction of nasolabial folds with a collagen implant.Gary D. Monheit, Ellen C. Gendler, Bradley Poff, Laura Fleming, Nathan Bachtell, Emily Garcia, David Burkholder> ;Dermatologic Surgery. 2010 Oct 22
- Join now to see all
Press Mentions
- Fourth Boy Dies in Trial of Astellas Gene Therapy CandidateSeptember 15th, 2021
- Astellas Reports Fourth Death in Orphan Disease Gene Therapy Clinical TrialSeptember 14th, 2021
- Another Death Blights Astellas’ $3B Audentes Buy, as FDA Slaps Clinical Hold on the TestSeptember 14th, 2021
- Join now to see all